Further experiments were carried out to verify and observe the staining of K562 cell apoptosis in each drug group, aiming to verify that Caulis Spatholobi may interfere with CML through PI3K-AKT and other signaling pathways. This evidence concerns the gene AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive.